TR200102043T2 - Hücre yapışma önleyicileri olarak monosakkaritlerin 2,3-O-izopropiliden türevleri. - Google Patents
Hücre yapışma önleyicileri olarak monosakkaritlerin 2,3-O-izopropiliden türevleri.Info
- Publication number
- TR200102043T2 TR200102043T2 TR2001/02043T TR200102043T TR200102043T2 TR 200102043 T2 TR200102043 T2 TR 200102043T2 TR 2001/02043 T TR2001/02043 T TR 2001/02043T TR 200102043 T TR200102043 T TR 200102043T TR 200102043 T2 TR200102043 T2 TR 200102043T2
- Authority
- TR
- Turkey
- Prior art keywords
- cell adhesion
- monosaccharides
- adhesion inhibitors
- isopropylidene
- prevention
- Prior art date
Links
- 230000021164 cell adhesion Effects 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title 1
- 150000002772 monosaccharides Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000007170 pathology Effects 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 201000003068 rheumatic fever Diseases 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Surgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN86DE1999 IN190975B (enExample) | 1999-01-15 | 1999-01-15 | |
| US09/276,368 US6590085B1 (en) | 1999-01-15 | 1999-03-25 | Derivatives of monosaccharides as cell adhesion inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200102043T2 true TR200102043T2 (tr) | 2001-11-21 |
Family
ID=11088155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/02043T TR200102043T2 (tr) | 1999-01-15 | 2000-01-10 | Hücre yapışma önleyicileri olarak monosakkaritlerin 2,3-O-izopropiliden türevleri. |
Country Status (30)
| Country | Link |
|---|---|
| US (5) | US6590085B1 (enExample) |
| EP (1) | EP1147119B1 (enExample) |
| JP (1) | JP2002534530A (enExample) |
| CN (1) | CN1167707C (enExample) |
| AR (1) | AR022235A1 (enExample) |
| AT (1) | ATE250074T1 (enExample) |
| AU (1) | AU768511B2 (enExample) |
| BG (1) | BG105745A (enExample) |
| BR (1) | BR0007553A (enExample) |
| CA (1) | CA2359986A1 (enExample) |
| CO (1) | CO5180591A1 (enExample) |
| CR (1) | CR6423A (enExample) |
| CZ (1) | CZ20012540A3 (enExample) |
| DE (1) | DE60005300T2 (enExample) |
| DK (1) | DK1147119T3 (enExample) |
| ES (1) | ES2206176T3 (enExample) |
| HR (1) | HRP20010529B1 (enExample) |
| HU (1) | HUP0105116A3 (enExample) |
| ID (1) | ID30351A (enExample) |
| IN (1) | IN190975B (enExample) |
| MA (1) | MA25342A1 (enExample) |
| MX (1) | MXPA01007187A (enExample) |
| MY (1) | MY121135A (enExample) |
| NZ (2) | NZ527483A (enExample) |
| PA (1) | PA8489901A1 (enExample) |
| PT (1) | PT1147119E (enExample) |
| SK (1) | SK284241B6 (enExample) |
| TR (1) | TR200102043T2 (enExample) |
| WO (1) | WO2000042054A1 (enExample) |
| YU (1) | YU50701A (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN190975B (enExample) * | 1999-01-15 | 2003-09-06 | Ranbaxy Lab Ltd | |
| CN1812983A (zh) | 2003-05-30 | 2006-08-02 | 兰贝克赛实验室有限公司 | 取代的吡咯衍生物及其作为hmg－co抑制剂的用途 |
| WO2006024926A1 (en) * | 2004-09-02 | 2006-03-09 | Ranbaxy Laboratories Limited | Monosaccharide derivatives |
| WO2007063356A2 (en) * | 2004-12-22 | 2007-06-07 | Ranbaxy Laboratories Limited | Derivatives of pentose monosaccharides as anti-inflammatory compounds |
| WO2007010499A2 (en) * | 2005-07-22 | 2007-01-25 | Ranbaxy Laboratories Limited | Derivatives of monosaccharides for the treatment of copd and allergic rhinitis |
| BRPI0618379A2 (pt) * | 2005-11-08 | 2011-08-30 | Ranbaxy Lab Ltd | processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico |
| CL2007000667A1 (es) * | 2006-03-14 | 2008-03-14 | Ranbaxi Lab Ltd | Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e |
| US20080114031A1 (en) * | 2006-03-29 | 2008-05-15 | Sattigeri Viswajanani J | Monosaccharide derivatives |
| US7790689B2 (en) * | 2006-05-30 | 2010-09-07 | Ranbaxy Laboratories Limited | Monosaccharide derivatives |
| US20080300196A1 (en) * | 2006-10-03 | 2008-12-04 | Ashwani Kumar Verma | Monosaccharide derivatives |
| US10034995B2 (en) * | 2007-09-20 | 2018-07-31 | Resmed Limited | Retractable tube for CPAP |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2715121A (en) | 1950-09-09 | 1955-08-09 | American Home Prod | Alkyl sugar derivatives and their preparation |
| US4056322A (en) | 1973-12-14 | 1977-11-01 | Strategic Medical Research Corporation | Preparation of ethers of monosaccharides |
| US4735934A (en) | 1981-02-17 | 1988-04-05 | Greenwich Pharmaceuticals Incorporated | Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease |
| US4996195A (en) * | 1989-01-09 | 1991-02-26 | Greenwich Pharmaceuticals Inc. | Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives |
| US5010058A (en) * | 1989-06-22 | 1991-04-23 | 501 Greenwich Pharmaceuticals Incorporated | 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives |
| FR2652540B1 (fr) | 1989-10-02 | 1995-06-02 | Imaje Sa | Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre. |
| US5192746A (en) | 1990-07-09 | 1993-03-09 | Tanabe Seiyaku Co., Ltd. | Cyclic cell adhesion modulation compounds |
| US5258402A (en) | 1992-06-11 | 1993-11-02 | Mcneil-Ppc, Inc. | Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates |
| US5432163A (en) | 1992-11-13 | 1995-07-11 | Greenwich Pharmaceuticals Incorporated | Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides |
| US5637570A (en) * | 1995-05-09 | 1997-06-10 | Chemora Pharmochem | Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity |
| IN190975B (enExample) * | 1999-01-15 | 2003-09-06 | Ranbaxy Lab Ltd |
-
1999
- 1999-01-15 IN IN86DE1999 patent/IN190975B/en unknown
- 1999-03-25 US US09/276,368 patent/US6590085B1/en not_active Expired - Fee Related
-
2000
- 2000-01-10 AR ARP000100086A patent/AR022235A1/es not_active Application Discontinuation
- 2000-01-10 CZ CZ20012540A patent/CZ20012540A3/cs unknown
- 2000-01-10 WO PCT/IB2000/000022 patent/WO2000042054A1/en not_active Ceased
- 2000-01-10 NZ NZ527483A patent/NZ527483A/en unknown
- 2000-01-10 JP JP2000593621A patent/JP2002534530A/ja active Pending
- 2000-01-10 NZ NZ512852A patent/NZ512852A/xx unknown
- 2000-01-10 ES ES00900088T patent/ES2206176T3/es not_active Expired - Lifetime
- 2000-01-10 AT AT00900088T patent/ATE250074T1/de not_active IP Right Cessation
- 2000-01-10 EP EP00900088A patent/EP1147119B1/en not_active Expired - Lifetime
- 2000-01-10 HR HR20010529A patent/HRP20010529B1/xx not_active IP Right Cessation
- 2000-01-10 DK DK00900088T patent/DK1147119T3/da active
- 2000-01-10 YU YU50701A patent/YU50701A/sh unknown
- 2000-01-10 MX MXPA01007187A patent/MXPA01007187A/es not_active IP Right Cessation
- 2000-01-10 PT PT00900088T patent/PT1147119E/pt unknown
- 2000-01-10 BR BR0007553-1A patent/BR0007553A/pt not_active IP Right Cessation
- 2000-01-10 SK SK10132001A patent/SK284241B6/sk unknown
- 2000-01-10 CA CA002359986A patent/CA2359986A1/en not_active Abandoned
- 2000-01-10 TR TR2001/02043T patent/TR200102043T2/xx unknown
- 2000-01-10 CN CNB008048525A patent/CN1167707C/zh not_active Expired - Fee Related
- 2000-01-10 ID IDW00200101520A patent/ID30351A/id unknown
- 2000-01-10 AU AU18861/00A patent/AU768511B2/en not_active Ceased
- 2000-01-10 HU HU0105116A patent/HUP0105116A3/hu unknown
- 2000-01-10 DE DE60005300T patent/DE60005300T2/de not_active Expired - Fee Related
- 2000-01-14 CO CO00001575A patent/CO5180591A1/es not_active Application Discontinuation
- 2000-01-14 PA PA20008489901A patent/PA8489901A1/es unknown
- 2000-01-14 MY MYPI20000121A patent/MY121135A/en unknown
-
2001
- 2001-07-12 MA MA26266A patent/MA25342A1/fr unknown
- 2001-07-12 CR CR6423A patent/CR6423A/xx not_active Application Discontinuation
- 2001-07-26 BG BG105745A patent/BG105745A/xx unknown
-
2003
- 2003-07-01 US US10/611,093 patent/US7005422B2/en not_active Expired - Fee Related
- 2003-07-01 US US10/610,719 patent/US7037899B2/en not_active Expired - Fee Related
- 2003-07-01 US US10/611,386 patent/US7005516B2/en not_active Expired - Fee Related
- 2003-07-01 US US10/611,091 patent/US20040018995A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE297203T1 (de) | Antithrombotische mitteln | |
| ATE306261T1 (de) | Antithrombosemittel | |
| BR9713465A (pt) | Inibidores metalotprotease de amina cìclica sibstituìda | |
| NO20072605L (no) | Nytt antranilinsyrederivat eller et salt derav | |
| EP1403255A4 (en) | RHO KINASE INHIBITORS | |
| ES533338A0 (es) | Derivados de la 2-pirimidinil-1-piperazina | |
| DE69931393D1 (de) | Antithrombotische amide | |
| TNSN07022A1 (fr) | Derives de pyridine | |
| ATE253545T1 (de) | Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren | |
| IL135536A0 (en) | Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same | |
| MA29926B1 (fr) | Derives de pyrazine | |
| PE20011314A1 (es) | DERIVADOS DE N-(4-CARBAMIMIDOIL-FENIL)-GLICINA COMO INHIBIDORES DE LA FORMACION DE FACTORES DE COAGULACION Xa IXa Y TROMBINA | |
| ECSP045378A (es) | Derivados novedosos de diazabiciclononeno | |
| TR200102043T2 (tr) | Hücre yapışma önleyicileri olarak monosakkaritlerin 2,3-O-izopropiliden türevleri. | |
| SE9804212D0 (sv) | Compounds | |
| MA26767A1 (fr) | Hydroxamates de sulfonamide | |
| MX9305364A (es) | Compuestos inhibidores de proteasa retroviral, metodo para su produccion y composicion farmaceutica que los comprende. | |
| DK1157998T3 (da) | Heterocykliske forbindelser, mellemprodukter derfor og elastaseinhibitorer | |
| MA27930A1 (fr) | Derives de nicotinamide utiles comme inhibiteurs de pde4 | |
| AU8811401A (en) | Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient | |
| FI844333A0 (fi) | 11-substituerade 5h,11h-pyrrolo/2,1-c/ /1,4/benzoxazepiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
| NO20010559L (no) | Fremgangsmate for syntese av (1H)-benzo[c]kinolizin-3-ones derivater | |
| DE60316436D1 (de) | Amidderivate als inhibitoren der enzymatischen aktivität von renin | |
| WO2003080631A3 (en) | Plasma carboxypeptidase b inhibitors | |
| ATE284882T1 (de) | Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe |